Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get your Portfolio automatically emailed to you up to 4 times a day with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Profound Medical Corp (PRN.TO)

Profound Medical Corp (PRN.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Profound Medical Corp 2400 Skymark Avenue Unit 6 Mississauga ON L4W 5K5 CAN

https://www.profoundmedical.com P: 647-476-1350 F: 647-847-3739

Sector:

N/A

Description:

Profound Medical Corp is a commercial-stage medical device company focused on the development and marketing of customizable, incision-free therapeutic systems for the image-guided ablation of diseased tissue utilizing its platform technologies and leveraging the healthcare system's existing imaging infrastructure. The company's product TULSA-PRO system combines real-time MRI, robotically driven transurethral sweeping-action thermal ultrasound with closed-loop temperature feedback control for the ablation of prostate tissue. The product is comprised of one-time-use devices and durable equipment that are used in conjunction with a customer's existing MRI scanner.

Key Statistics

Overview:

Market Capitalization, $K 362,558
Shares Outstanding, K 35,372
Annual Sales, $ 10,680 K
Annual Net Income, $ -27,816 K
Last Quarter Sales, $ 5,289 K
Last Quarter Net Income, $ -7,977 K
60-Month Beta -0.91
% of Institutional Shareholders 12.15%

Growth:

1-Year Return -3.71%
3-Year Return -29.21%
5-Year Return -60.86%
5-Year Revenue Growth 20.67%

Per-Share Information:

Most Recent Earnings -0.26 on 11/13/25
Next Earnings Date N/A
Earnings Per Share ttm -1.32
EPS Growth vs. Prev Year 0.00%
Dividend Payout Ratio 0.00%
Most Recent Split 1-10 on 10/16/19

PRN.TO Ratios

Ratio
Price/Earnings ttm N/A
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -124.49%
Return-on-Assets % -93.07%
Profit Margin % -260.45%
Debt/Equity 0.05
Price/Sales 15.21
Price/Book 8.24
Book Value/Share 1.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar